|
Market Closed -
Bombay S.E.
14:02:22 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 169.55 INR | +3.51% |
|
+2.54% | +106.14% |
| Market Cap | 49.77B 520M 446M 417M 382M 716M 726M 4.93B 1.92B 25B 1.95B 1.91B 82.69B | P/E 2027 * |
22.6x | P/E 2028 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 49.77B 520M 446M 417M 382M 716M 726M 4.93B 1.92B 25B 1.95B 1.91B 82.69B | EV / Sales 2027 * |
1.81x | EV / Sales 2028 * | 1.58x |
| Free-Float |
33.91% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: IOL Chemicals and Pharmaceuticals Limited
| 1 day | +3.51% | ||
| 1 week | +2.54% | ||
| Current month | +15.97% | ||
| 1 month | +14.44% | ||
| 3 months | +42.73% | ||
| 6 months | +131.15% | ||
| Current year | +106.14% |
| 1 week | 155.15 | 175.5 | |
| 1 month | 143.55 | 178.5 | |
| Current year | 67.14 | 179.65 | |
| 1 year | 67.14 | 179.65 | |
| 3 years | 57.51 | 179.65 | |
| 5 years | 54.44 | 179.65 | |
| 10 years | 8.4 | 179.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 14/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Varinder Gupta
CHM | Chairman | 63 | 01/09/2007 |
Vikas Gupta
BRD | Director/Board Member | 34 | 29/05/2015 |
| Chairman | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.51% | +2.54% | +75.06% | +128.26% | 520M | ||
| +0.88% | +6.38% | +76.40% | +126.75% | 1,119B | ||
| +1.07% | +3.80% | +50.73% | +62.78% | 651B | ||
| +1.20% | +6.21% | +25.81% | +78.74% | 468B | ||
| +1.02% | +5.77% | +43.63% | +48.43% | 374B | ||
| +0.85% | +4.07% | +24.97% | +40.58% | 302B | ||
| +1.26% | +6.81% | +2.27% | +14.41% | 259B | ||
| +1.88% | +5.81% | +49.57% | +70.53% | 238B | ||
| +1.59% | +2.09% | -17.33% | -52.62% | 208B | ||
| +1.87% | +5.61% | +27.32% | +91.38% | 181B | ||
| Average | +1.51% | +4.73% | +35.84% | +60.92% | 380.04B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.27% | +72.66% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 27.42B 287M 246M 230M 210M 395M 400M 2.71B 1.06B 13.78B 1.08B 1.05B 45.57B | 31.52B 329M 282M 264M 242M 454M 460M 3.12B 1.22B 15.84B 1.24B 1.21B 52.38B |
| Net income | 2.2B 22.97M 19.68M 18.41M 16.85M 31.63M 32.05M 218M 84.83M 1.1B 86.26M 84.38M 3.65B | 2.84B 29.68M 25.43M 23.79M 21.78M 40.87M 41.41M 281M 110M 1.43B 111M 109M 4.72B |
| Net Debt | - | - |
Employees
3,095
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | ₹169.55 | +3.51% | 435,008 |
| 20/08/26 | ₹163.80 | +4.33% | 153,811 |
| 19/08/26 | ₹157.00 | -1.66% | 105,961 |
| 18/08/26 | ₹159.65 | -1.15% | 76,249 |
| 17/08/26 | ₹161.50 | -2.33% | 109,539 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
169.55INR
Average target price
197.00INR
Spread / Average Target
+16.19%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IOLCP Stock
Select your edition
All financial news and data tailored to specific country editions

















